The majority of newly diagnosed myeloma patients do not fulfill the inclusion criteria in clinical phase III trials

Leukemia. 2019 Feb;33(2):546-549. doi: 10.1038/s41375-018-0272-0. Epub 2018 Sep 28.
No abstract available

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Clinical Trials, Phase III as Topic / statistics & numerical data*
  • Guideline Adherence*
  • Humans
  • Multiple Myeloma / diagnosis*
  • Multiple Myeloma / therapy*
  • Patient Selection*
  • Registries
  • Research Design / standards*